In a new public consultation response, BioMed Alliance shares its views on the proposed implementing regulation detailing procedural rules for the cooperation of the Member State Coordination Group on Health Technology Assessment (HTA) and the Commission with the European Medicines Agency. While welcoming the draft regulation, the Alliance also shares key recommendations on the timely and efficient exchange of information, creating synergies, involving experts, and balanced conflict of interest policies. The feedback is published on the EU Have Your Say Portal here, and replies to the consultation will be considered before the final regulation is adopted.
